Protagenic Therapeutics, Inc.\new Logo

Protagenic Therapeutics, Inc.\new

Develops peptide-based therapeutics for stress-related neuropsychiatric disorders.

PTIX | US

Overview

Corporate Details

ISIN(s):
US74365N2027 (+1 more)
LEI:
Country:
United States of America
Address:
149 FIFTH AVENUE, 10010 NEW YORK

Description

Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on developing peptide-based therapeutics for stress-related disorders. The company's core technology is its TCAP (teneurin C-terminal associated peptide) platform, which utilizes neuropeptides to regulate the brain's stress response at a cellular level. This approach aims to counteract the 'Stress Feedback Loop' implicated in various neuropsychiatric and neurodegenerative conditions. Its lead drug candidate, PT00114, a synthetic TCAP, is being developed as a potential first-in-class treatment for disorders such as anxiety and depression.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-05 22:52
DEF 14A
English 49.2 KB
2025-11-26 23:26
10-Q
English 1.2 MB
2025-11-26 22:18
8-K
English 116.8 KB
2025-11-14 23:04
NT 10-Q
English 10.8 KB
2025-11-05 22:21
8-K
English 77.3 KB
2025-10-31 22:08
8-K
English 25.2 MB
2025-10-24 23:29
424B5
English 116.4 KB
2025-10-24 19:40
PRIMARY DOCUMENT
English 7.4 KB
2025-09-17 18:21
8-K/A
English 118.2 KB
2025-09-10 22:06
10-QT
English 1.1 MB
2025-08-28 00:28
8-K/A
English 306.4 KB
2025-08-25 22:07 English 8.8 KB
2025-08-22 23:28
8-K
English 1.6 MB
2025-08-14 22:56
NT 10-Q
English 12.0 KB
2025-08-13 23:16
8-K
English 86.9 KB

Automate Your Workflow. Get a real-time feed of all Protagenic Therapeutics, Inc.\new filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Protagenic Therapeutics, Inc.\new

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Protagenic Therapeutics, Inc.\new via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alpha Tau Medical Ltd. Logo
Clinical-stage oncology firm developing alpha radiation therapy for solid tumors.
United States of America
DRTS
Alteogen Inc. Logo
Biopharmaceutical firm developing biologics with proprietary drug delivery technologies.
South Korea
196170
AlzeCure Pharma Logo
Develops therapies for severe diseases, focusing on Alzheimer's and pain.
Sweden
ALZCUR
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapeutics for inflammatory diseases.
United States of America
ANAB
AngioLab, Inc. Logo
Develops angiogenesis inhibitors for pharmaceuticals and health functional foods.
South Korea
251280
Anixa Biosciences Inc Logo
A clinical-stage biotech developing therapies and vaccines to treat and prevent cancer.
United States of America
ANIX
Annovis Bio, Inc. Logo
A clinical-stage drug platform company developing therapies for neurodegenerative diseases.
United States of America
ANVS
Develops and manufactures DNA-based technologies for genetic medicine and diagnostics.
United States of America
APDN
Aprea Therapeutics, Inc. Logo
Clinical-stage biopharma developing cancer therapeutics via synthetic lethality.
United States of America
APRE
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
South Korea
397030

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.